Skip to main content
Clinical Trials/DRKS00018784
DRKS00018784
Completed
Not Applicable

Identification of miRNA biomarker signature for diagnosis and monitoring of lung diseases (ALLmiR-Study) - ALLmiR-Study

Hummingbird Diagnostics GmbH0 sites1,050 target enrollmentNovember 18, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C34
Sponsor
Hummingbird Diagnostics GmbH
Enrollment
1050
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 18, 2019
End Date
July 31, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or female, \=18 years old, Therapy naïve, Respiratory complaints, sufficient knowledge of German, Willingness to participate in study

Exclusion Criteria

  • Known infectious diseases (HIV, HCV, HBV), Advanced, curatively\-treated cancer within last 5 years

Outcomes

Primary Outcomes

Not specified

Similar Trials